Drug intelligence / Profile preview

1-[N-4'-nitrobenzyl-N-4'-carboxybutylamino]methylphosphonic acid

Development stage: Unknown
Modality: Small Molecules

Overview

1-[N-4'-nitrobenzyl-N-4'-carboxybutylamino]methylphosphonic acid is an experimental small molecule belonging to the class of nitrobenzenes, characterized by a nitrobenzene moiety and a phosphonic acid group. It has been studied primarily as a hapten in structural biology, notably in complex with catalytic antibody fragments such as the 28B4 Fab fragment. Its main use appears to be as a model compound for studying antibody-hapten interactions and catalytic antibodies rather than as a therapeutic agent. There is no evidence of clinical development or approved medical indications for this compound[1][2][3][4].

Other names: 5-{[(4-nitrophenyl)methyl](phosphonomethyl)amino}pentanoic acid

Beyond the preview

Go deeper on 1-[N-4'-nitrobenzyl-N-4'-carboxybutylamino]methylphosphonic acid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on 1-[N-4'-nitrobenzyl-N-4'-carboxybutylamino]methylphosphonic acid.

Explore the full profile